DK1322305T3 - Anvendelse af R-arylpropionsyrer til fremstilling af lægemidler til behandling af lidelser af rheumatisk natur - Google Patents

Anvendelse af R-arylpropionsyrer til fremstilling af lægemidler til behandling af lidelser af rheumatisk natur

Info

Publication number
DK1322305T3
DK1322305T3 DK01983497T DK01983497T DK1322305T3 DK 1322305 T3 DK1322305 T3 DK 1322305T3 DK 01983497 T DK01983497 T DK 01983497T DK 01983497 T DK01983497 T DK 01983497T DK 1322305 T3 DK1322305 T3 DK 1322305T3
Authority
DK
Denmark
Prior art keywords
drugs
manufacture
treatment
arylpropionic acids
rheumatic disorders
Prior art date
Application number
DK01983497T
Other languages
English (en)
Inventor
Gerd Geisslinger
Sabine Groesch
Original Assignee
Paz Arzneimittelentwicklung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paz Arzneimittelentwicklung filed Critical Paz Arzneimittelentwicklung
Application granted granted Critical
Publication of DK1322305T3 publication Critical patent/DK1322305T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01983497T 2000-09-25 2001-09-24 Anvendelse af R-arylpropionsyrer til fremstilling af lægemidler til behandling af lidelser af rheumatisk natur DK1322305T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10047319A DE10047319A1 (de) 2000-09-25 2000-09-25 Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen, welche durch die Hemmung der Aktivierung des nukleären Transkriptionsfaktors AP-1 therapeutisch beeinflußt werden können

Publications (1)

Publication Number Publication Date
DK1322305T3 true DK1322305T3 (da) 2006-04-10

Family

ID=7657456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01983497T DK1322305T3 (da) 2000-09-25 2001-09-24 Anvendelse af R-arylpropionsyrer til fremstilling af lægemidler til behandling af lidelser af rheumatisk natur

Country Status (9)

Country Link
US (1) US8092829B2 (da)
EP (1) EP1322305B1 (da)
JP (1) JP2004509145A (da)
AT (1) ATE311866T1 (da)
CY (1) CY1104977T1 (da)
DE (2) DE10047319A1 (da)
DK (1) DK1322305T3 (da)
ES (1) ES2254516T3 (da)
WO (1) WO2002024190A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004086A1 (en) * 2000-04-13 2006-01-05 Mayo Foundation For Medical Education And Research Method of reducing Abeta42 and treating diseases
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
PT2387391T (pt) * 2009-07-24 2017-04-20 Mika Pharma Ges Für Die Entw Und Vermarktung Pharmazeutischer Produkte Mbh Processo para o desenvolvimento de uma composição líquida a ser aplicada na forma de espuma sobre a pele e composição de aplicação tópica
EP2468270A1 (en) 2010-12-21 2012-06-27 GALENpharma GmbH (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
US9346803B2 (en) 2011-10-17 2016-05-24 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
US20150183737A1 (en) * 2012-07-20 2015-07-02 Vanderbilt University Compositions and methods for substrate-selective inhibition of endocannabinoid oxygenation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
US5331000A (en) 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
WO1994020449A1 (en) * 1993-03-09 1994-09-15 Dompe'farmaceutici Spa Salts of 2-(3-benzoylphenyl)propionic acid with achiral and chiral organic bases and pharmaceutical compositions thereof
DE4319438C1 (de) 1993-06-11 1994-06-01 Gerd Dr Dr Geislinger Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren
DE19716713A1 (de) 1997-04-21 1998-10-22 Paz Arzneimittelentwicklung Arzneimittel, enthaltend Ibuprofenthioester als Hemmer der Nf-kappaB abhängigen Bildung von Mediatoren von Entzündung und Schmerz
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
ES2281981T3 (es) * 1998-09-03 2007-10-01 Loma Linda University Medical Center Composicion farmaceutica y uso de aines para tratar la inflamacion.
DE19907895A1 (de) * 1999-02-24 2000-11-16 Paz Arzneimittelentwicklung Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen bei Mensch und Tier, welche durch die Hemmung der Aktivierung von NF-kB therapeutisch beeinflußt werden können

Also Published As

Publication number Publication date
ES2254516T3 (es) 2006-06-16
CY1104977T1 (el) 2009-11-04
DE50108339D1 (de) 2006-01-12
WO2002024190A1 (de) 2002-03-28
EP1322305B1 (de) 2005-12-07
DE10047319A1 (de) 2002-04-18
US20040037876A1 (en) 2004-02-26
EP1322305A1 (de) 2003-07-02
JP2004509145A (ja) 2004-03-25
US8092829B2 (en) 2012-01-10
ATE311866T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
NO20054228L (no) Anvendelse av (IS,2R)-enantiomeren av milnacipran for fremstillingen av et medikament
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
CY1108287T1 (el) Χρηση του εναντιομερους (1s, 2r) της μιλνακιπρανης για την παρασκευη ενος φαρμακου
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
BR0008979A (pt) Composto quìmico, uso de um composto, método de tratamento, processo de preparação de um composto, composição farmacêutica e método de fabricação da mesma
CY1106774T1 (el) Συνθεσεις φαρμακευτικων μεσων με βαση αλατα του τιοτροπιου και αλατα της σαλμετερολης
BR0309185A (pt) Medicamento contendo beta-miméticos e um novo anticolinérgico
CY1106375T1 (el) Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας
DE50108339D1 (de) Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln zur behandlung von erkrankungen rheumatischer natur
BR0315580A (pt) Derivados de metileno uréia
EA200971087A1 (ru) Фармацевтические композиции и способ лечения острой мании
DK2244703T3 (da) Lægemiddel og fremstillingen og anvendelse deraf i behandlingen af smertefulde neuropatier
DK1583538T3 (da) Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme
DK1594885T3 (da) Lægemiddel til vækstinhibering af tumorer
RU2008127882A (ru) Лечение пищевода барретта
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
IS2214B (is) Meðhöndlun á mígreni með því að gefa inn alfa-lípósýru eða afleiður hennar
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса
TW200507853A (en) Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
UY26990A1 (es) Nuevas composiciones de medicamentos
ATE295845T1 (de) Prucaloprid-n-oxid
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
MY138165A (en) Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome
ITTO20050220A1 (it) Nuova utilizzazione terapeutica della molsidomina e dei suoi sali farmaceuticamente accettabili
ECSP003424A (es) NUEVAS COMPOSICIONES DE MEDICAMENTOS A BASE DE COMPUESTOS ANTICOLINERGICAMENTE ACTIVOS Y ß-MIMETICOS